Skip to content

Prevention and Treatment of Digital Ulcers in Systemic Sclerosis

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01836263
Enrollment
420
Registered
2013-04-19
Start date
2013-04-30
Completion date
2017-06-30
Last updated
2013-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systemic Sclerosis, Ulcer

Brief summary

Systemic sclerosis is an orphan, multiorgan disease affecting the connective tissue of the skin and several internal organs. Digital ulcers are frequent and have a major impact on the quality of life in patients with systemic sclerosis. The etiology of digital ulcers is complex and multifactorial and the principal mechanisms underlying the digital ulcers formation are ischemic, mechanic and inflammatory, alone or in combination, on the basis of the systemic sclerosis vasculopathy. Consequently, there are at least three types of DU: (i) those localized at the tips of the fingers and toes, mainly resulting from an ischemic process, (ii) those localized on the dorsal aspect of the fingers where the skin retraction due to fibrosis over bony prominences seems to be the main cause, and (iii) those evolving on a pitting scar or subcutaneous calcinosis due to a combined irritative-inflammatory mechanism. An early therapy to prevent or rapidly heal digital ulcers is today considered a mandatory approach to maintain quality of life and spare the enormous costs due to conventional digital ulcer management. This observational trial is part of the collaborative project DeSScipher, one out of five observational trials to decipher the optimal management of systemic sclerosis. Aim of this observational trial is: 1. To identify the best treatment combination for prevention of digital ulcers in patients with fulfilment of the new ACR/EULAR SSc criteria or the preliminary VEDOSS criteria for very early diagnosis of systemic sclerosis 2. To identify the best treatment associated with improved healing of digital ulcers in patients with fulfilment of the new ACR/EULAR SSc criteria Thus, the observational trial consist of a prevention arm and a healing arm.

Interventions

None listed

Sponsors

European Union
CollaboratorOTHER
University of Giessen
CollaboratorOTHER
University of Zurich
CollaboratorOTHER
University of Paris 5 - Rene Descartes
CollaboratorOTHER
University of Campania Luigi Vanvitelli
CollaboratorOTHER
University of Basel
CollaboratorOTHER
University College, London
CollaboratorOTHER
Charite University, Berlin, Germany
CollaboratorOTHER
University of Pecs
CollaboratorOTHER
University of Leeds
CollaboratorOTHER
Schoen Klinik Hamburg Eilbek
CollaboratorOTHER
marco matucci cerinic
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Juvenile and adult patients with diagnosis of systemic sclerosis according to the ACR/EULAR SSc criteria or the PRES/ACR/EULAR juvenile SSc criteria for enrollment into the prevention and healing arm * Patients with fulfilment of the preliminary criteria for very eary diagnosis of systemic sclerosis (VEDOSS criteria) for enrollment into the prevention arm Patients with active digital ulcers will be allocated into the healing arm. Patients without previous or history of digital ulcers (but currently without active digital ulcers) will be allocated into the prevention arm. Definition of digital ulcers (DU): DU are 1) loss of tissue, 2) DU derived from digital pitting scars and 3) DU derived from calcinosis. IN THIS STUDY WE CONSIDER ONLY DU (1) LOSS OF TISSUE. THE OTHER DU (2) and DU (3) ARE REGISTERED IN THE DATA BASE IF THEY ARE PRESENT, BUT ARE EXCLUDED FROM EVALUATION.

Design outcomes

Primary

MeasureTime frame
Prevention arm: Number of new digital ulcers24 months
Healing arm: Time to healing of manifest digital ulcers24 months

Secondary

MeasureTime frame
Prevention arm: Time to development of new digital ulcers24 months
Healing arm: Number of healed digital ulcers24 months

Other

MeasureTime frameDescription
Prevention arm: novel composite digital ulcer prediction score24 monthsPrevention: A novel composite digital ulcers prediction score which will be tested against the already proposed capillaroscopic prediction score CSURI
Healing arm: novel composite outcome score for the assessment of worsening of digital ulcers despite treatment24 monthsHealing: A novel composite outcome score for the assessment of worsening of digital ulcers despite treatment

Countries

France, Germany, Hungary, Italy, Switzerland, United Kingdom

Contacts

Primary ContactMarco Matucci-Cerinic, Prof.
marco.matuccicerinic@unifi.it
Backup ContactFrancesco Del Galdo, Prof.
F.DelGaldo@leeds.ac.uk

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026